![Henna KD on Twitter: "Inhaled steroids have been linked to increased pneumonia esp. n the elderly. We are moving towards LAMA+LABA combination inhalers for COPD. https://t.co/rJsiKkPnUU" / Twitter Henna KD on Twitter: "Inhaled steroids have been linked to increased pneumonia esp. n the elderly. We are moving towards LAMA+LABA combination inhalers for COPD. https://t.co/rJsiKkPnUU" / Twitter](https://pbs.twimg.com/media/CytQ4InXEAAYpUe.jpg)
Henna KD on Twitter: "Inhaled steroids have been linked to increased pneumonia esp. n the elderly. We are moving towards LAMA+LABA combination inhalers for COPD. https://t.co/rJsiKkPnUU" / Twitter
![Los broncodilatadores inhalados continúan siendo el tratamiento de mantenimiento de elección en la epoc | Conectados Los broncodilatadores inhalados continúan siendo el tratamiento de mantenimiento de elección en la epoc | Conectados](https://pro.boehringer-ingelheim.com/sa/sites/default/files/2021-06/placeholder.png)
Los broncodilatadores inhalados continúan siendo el tratamiento de mantenimiento de elección en la epoc | Conectados
![LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment | European Respiratory Society LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment | European Respiratory Society](https://err.ersjournals.com/content/errev/26/143/160043/F1.large.jpg)
LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment | European Respiratory Society
![SOCIEM UCV sur Twitter : "No hubo diferencias entre el tratamiento LABA y LAMA. En comparación con LABA, hubo un aumento pequeño pero significativo en el FEV1 mínimo después del tratamiento con SOCIEM UCV sur Twitter : "No hubo diferencias entre el tratamiento LABA y LAMA. En comparación con LABA, hubo un aumento pequeño pero significativo en el FEV1 mínimo después del tratamiento con](https://pbs.twimg.com/media/Ea1U0DDWkAAKKsp.jpg)
SOCIEM UCV sur Twitter : "No hubo diferencias entre el tratamiento LABA y LAMA. En comparación con LABA, hubo un aumento pequeño pero significativo en el FEV1 mínimo después del tratamiento con
![Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41533-020-00205-9/MediaObjects/41533_2020_205_Fig3_HTML.png)
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
![Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/14237d6f07c90838ca1277212ca4bae185748743/9-Table2-1.png)
Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar
![Treatment with LABA versus LAMA for stable COPD: a systematic review and meta-analysis | BMC Pulmonary Medicine | Full Text Treatment with LABA versus LAMA for stable COPD: a systematic review and meta-analysis | BMC Pulmonary Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12890-020-1152-8/MediaObjects/12890_2020_1152_Fig3_HTML.png)
Treatment with LABA versus LAMA for stable COPD: a systematic review and meta-analysis | BMC Pulmonary Medicine | Full Text
![Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/14237d6f07c90838ca1277212ca4bae185748743/5-Table1-1.png)
Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar
![Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - The Journal of Allergy and Clinical Immunology: In Practice Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - The Journal of Allergy and Clinical Immunology: In Practice](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d39901ad-83ef-4cbf-a356-8d18551ddee8/gr1.jpg)